ArticleRevista de saude publica2017
Factors associated with the contraindicated use of oral contraceptives in Brazil.
Article in Revista de saude publica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 213 citations in OpenAlex.
- Cardiovascular risk profile according to World Health Organization medical eligibility criteria for contraceptive use of women using hormonal contraception in Rio de Janeiro state, Brazil.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026Article
- Trends in traffic accident mortality and social inequalities in Ecuador from 2011 to 2022.BMC public health · 2024Article
- The financing of medicines in Brazilian municipalities: whose responsibility is it?Revista de saude publica · 2024Article
- Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort.Revista de saude publica · 2024Article
- Quality of prescription writing in Brazilian primary health care.Primary health care research & development · 2023Observational
- Analysis of access to health services in Brazil according to sociodemographic profile: National Health Survey, 2019.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2022Article
- Article
- The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study.International journal of environmental research and public health · 2022Article
- Omeprazole use and risk of chronic kidney disease evolution.PloS one · 2020Article
- Spatial and temporal analysis of tuberculosis in an area of social inequality in Northeast Brazil.BMC public health · 2019Article
- Social inequalities in the use of contraceptives in adult women from Southern Brazil.Revista de saude publica · 2019Article
- Parental Perceived Travel Time to and Reported Use of Food Retailers in Association with School Children's Dietary Patterns.International journal of environmental research and public health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women.
methods20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals.
resultsIn the total population, 21% (95%CI 19.7-21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6-13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57-3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34-6.83) and 45-49 years (PR = 5.59; 95%CI 2.90-10.75).
conclusionsAge greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptives. OBJETIVO: Estimar a prevalência de contraindicação ao uso de anticoncepcionais orais e os fatores associados em mulheres brasileiras. MÉTODOS: Participaram 20.454 mulheres que responderam ao inquérito Vigitel em 2008, das quais 3.985 reportaram uso de contraceptivos orais. Definiu-se como uso contraindicado de anticoncepcionais quando presente pelo menos uma condição: hipertensão; doenças cardiovasculares como infarto, derrame/acidente vascular encefálico; diabetes mellitus; ser tabagista e ter idade igual ou maior de 35 anos. Foram estimadas as prevalências e intervalos de 95% de confiança de uso contraindicado em usuárias de anticoncepcionais orais e fatores associados à contraindicação por meio de razões de prevalência e intervalos de 95% de confiança. RESULTADOS: Na população total, 21,0% (IC95% 19,7-21,9) das mulheres apresentaram alguma contraindicação ao uso de anticoncepcionais orais, das quais 11,7% (IC95% 10,6-13,7) pertenciam ao grupo de usuárias de anticoncepcionais orais. A contraindicação mais freqüente entre as usuárias de anticoncepcionais orais foi hipertensão (9,1%). A maior proporção de mulheres com pelo menos uma contraindicação tinha entre 45 a 49 anos (45,8%) e escolaridade entre zero e oito (23,8%). A prevalência de contraindicação de anticoncepcionais orais foi maior nas mulheres menos escolarizadas (zero a oito anos de estudos) (RP = 2,46; IC95% 1,57-3,86; p < 0,05) e idade entre 35-44 anos (RP = 4,00; IC95% 2,34-6,83) e 45-49 anos (RP = 5,59; IC95% 2,90-10,75). CONCLUSÕES: Idade maior ou igual a 35 e escolaridade baixa foram fatores demográficos e de iniquidade, respectivamente, no uso contraindicado de contraceptivos orais.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.